Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
Childhood Cancer International Day
In France, childhood cancer affects 1 child in 500. It is the second commonest cause of mortality in those under 15 years of age. The number of patients cured continues to rise and today, 80% are cured of their cancer. At Gustave Roussy, all our professional staff work together every day to make the Child and Adolescent Cancer Department an innovative unit in research and care.
Published on
Changed on
In France, childhood cancer affects 1 child in 500. It is the second commonest cause of mortality in those under 15 years of age. The number of patients cured continues to rise and today, 80% are cured of their cancer. At Gustave Roussy, all our professional staff work together every day to make the Child and Adolescent Cancer Department an innovative unit in research and care.
In 1950, Gustave Roussy created the first Paediatric Cancer Unit in France which is the origin of:
- innovative treatments which today are worldwide treatment recommendations;
- research studies to reduce sequellae due to the treatment and the illness;
- early trials on new medicines;
- a law to encourage the pharmaceutical industry to draw to a close the use of medicines for the treatment of children which are effective in adults.
Overseen by Dr Dominique Valteau-Couanet, this department manages all types of paediatric cancer: neuroblastomas, cerebral tumours, bone and soft tissue tumours, lymphomas, stem cell tumours and rare tumours. Each department physician is an expert at the National, European and International level.
Special attention focuses on:
- Appropriate treatment and access to new treatments
- The quality of care within and outside the hospital environment
- The readaptation to life after the illness
- Long term survival.
In order to attain a better overall management, innovative and centred on the needs of young patients, the children and adolescent cancer department of Gustave Roussy has benefited from a thorough architectural restructuring. These new premises were inaugurated in December 2014.
Last news
-
Breast Cancer: Gustave Roussy Ranked No. 1 in France for Breast Surgery and Breast Reconstruction
On the occasion of Breast Cancer Awareness Month, the 2025 data from Visuchir, the national surgical activity monitoring tool of the French Health Insurance system, places Gustave Roussy in first position for both breast surgery and breast reconstruction. Beyond this ranking, these figures highlight that reconstruction is now an integral part of breast cancer treatment. It is considered at every stage of care: from tumor removal surgery, whether lumpectomy or mastectomy, through to the post-cancer period, helping to restore the body and support women in regaining their physical integrity and quality of life.
-
Newsweek Ranking: Gustave Roussy Named Europe’s Leading Cancer Centre and Third Best Worldwide
The 2027 edition of Newsweek’s World's Best Specialized Hospitals ranking once again recognises Gustave Roussy as the leading cancer centre in France and Europe, and the third best worldwide. This distinction highlights the excellence of the Institute’s care and research, as well as the daily commitment of all its professionals.
-
Living with and beyond cancer: the promises and challenges of digital health
In a Viewpoint article published in The Lancet Digital Health, Drs Ines Vaz-Luis and Maria Alice Franzoi, together with Emmanuel Mussault, a patient partner at the PRISM University Hospital Institute, examine the role that digital tools can play in supporting people living with and beyond cancer. Their central message is that these technologies can support more personalised and accessible care, but their value depends primarily on how they are integrated into care pathways, the human support provided, their ability to address individual needs and their evaluation in real-world settings.
-
Gustave Roussy and The Lancet launch an international lecture series on innovations transforming cancer care
The inaugural lecture in the “Lecture Series on Cancer Breakthroughs” will take place on Friday 18 September at 5:00 pm. It will be delivered by Professor Timothy R. Rebbeck, a leading cancer prevention specialist at Harvard University and the Dana-Farber Cancer Institute.
